Global Influenza Diagnostics market promulgates due to the rise in the incidence of influenza across the world and the rising demand for rapid disease diagnosis
The global influenza diagnostics market projected to grow at a CAGR of over 7.5% during the forecast period, 2020-2027. It is primarily attributed to the growing amount of research and development, technological advancements in diagnostic tests, and increasing demand for influenza diagnosis. Additionally, the rising aging population as old aged people are more vulnerable to influenza along with the introduction of technologically advanced influenza diagnostic tests that will spur the growth of global influenza diagnostics market size in the next few years. Moreover, growing awareness about the disease coupled with the rising healthcare expenditure, various governments’ authorities dedicated towards R&D of influenza treatments and diagnostics are projected to trigger the global influenza diagnostics industry.
Furthermore, the upsurge in the geriatric population, which is a high risk of contracting influenza and the increase in chronic disease around the world, are fuelling the demand for influenza diagnostics products. Technological developments in advanced influenza diagnostic tests and the rising prevalence of chronic diseases across the globe will trigger the growth of the global influenza diagnostics market in the forecast span. Also, the upsurge in awareness regarding influenza, especially in the developing regions and the rise in healthcare expenditure by governments towards R&D of influenza diagnosis and therapeutic will boost the growth of influenza diagnostics market share.
Further, recent diagnostics test such viral nucleic acid detection based on fast multiplex PCR has the advantages of rapid detection speed, high sensitivity, and specificity, simultaneous detection of multiple common respiratory pathogens and accurate typing, etc., which can better help clinical respiratory infection diagnosis and treatment.
Test Type Overview in the Global Influenza Diagnostics Market
Based on Test type, the global influenza diagnostics market classified into Traditional Diagnostic Tests (RIDT, Viral Culture, DFA, and Serological Assays), Molecular Diagnostic Tests(RT-PCR, Isothermal Nucleic Acid Amplification Tests, and Others) and Others. The RIDT will be the fastest-growing segment in the forecast period. It is attributable to these tests are antigen detection assesses that detect influenza viral antigens within 10 to 15 minutes with high specificity. It can detect the presence of influenza type A and B in specimens.
RT-PCR will grow with a significant rate in the forecast period due to these tests potentially determine the influenza virus type (A and B viruses), and the chance for negative or false-positive results are very low.
End-User Overview in the Global Influenza Diagnostics market
Based on end-user, the global influenza diagnostics market segregated into hospitals, Clinical Laboratories, Research Centers, and Point of Care Testing Centers. The hospital held for the highest revenue in 2019 due to the hospitals are long-term care facilities, which are the primary end-use segment in underdeveloped and developing countries, as most people rely on them for diagnosing influenza.
Point of Care Testing Centers will be the fastest-growing segment during the forecast period as POCT is primarily used for influenza diagnostic testing kits and technological advancements in the POC test kits, which take shorter turnaround times and error-free result.
Regional Overview in the Global Influenza Diagnostics Market
By geography, the Global Influenza Diagnostics Market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America accounted for maximum revenue share in 2019, owing to the huge arrangement of influenza-associated hospitals, the presence of healthcare reimbursement schemes and research institutions, and a strong focus of the U.S. CDC on controlling the disease rates.
Global Influenza Diagnostics Market: Competitive Landscape
Companies such as F. Hoffmann-La Roche AG, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Hologic, Becton, Dickinson, and Company, DiaSorin S.p.A, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, SA Scientific, Sekisui Diagnostics, bioMérieux SA, Danaher Corporation, Siemens Healthineers, Tecan Trading AG, ELITech, Mast Group, Altona Diagnostics, Coris BioConcept, and Genome Diagnostics are the key players in the global influenza diagnostics market.
'
1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
3. Executive Summary
4. Market Insights
4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Technological Landscape
4.3. Competitors & Product Analysis
4.4. Regulatory Framework
4.5. Company market share analysis, 2019
4.6. Porter’s Five forces analysis
4.7. New Investment Analysis
4.8. PESTEL Analysis
5. Global Influenza Diagnostics Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Test Type
5.2.1.1. Traditional Diagnostic Tests
5.2.1.1.1. RIDT
5.2.1.1.2. Viral Culture
5.2.1.1.3. DFA
5.2.1.1.4. Serological Assays
5.2.1.2. Molecular Diagnostic Tests
5.2.1.2.1. RT-PCR
5.2.1.2.2. Isothermal Nucleic Acid Amplification Tests
5.2.1.2.3. Others
5.2.1.3. Others
5.2.2. By End-Users
5.2.2.1. Hospital
5.2.2.2. Clinical Laboratories
5.2.2.3. Research Centers
5.2.2.4. Point Of Care Testing Centers
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia Pacific
5.2.3.4. South America
5.2.3.5. Middle East & Africa
6. North America Influenza Diagnostics Market Overview
6.1. North America Influenza Diagnostics Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. North America Influenza Diagnostics Market Share & Forecast, 2016-2027
6.2.1. By Test Type
6.2.1.1. Traditional Diagnostic Tests
6.2.1.1.1. RIDT
6.2.1.1.2. Viral Culture
6.2.1.1.3. DFA
6.2.1.1.4. Serological Assays
6.2.1.2. Molecular Diagnostic Tests
6.2.1.2.1. RT-PCR
6.2.1.2.2. Isothermal Nucleic Acid Amplification Tests
6.2.1.2.3. Others
6.2.1.3. Others
6.2.2. By End-User
6.2.2.1. Hospital
6.2.2.2. Clinical Laboratories
6.2.2.3. Research Centers
6.2.2.4. Point Of Care Testing Centers
6.2.3. By Country
6.2.3.1. US
6.2.3.2. Canada
6.2.3.3. Mexico
6.2.4. Price-Point Analysis
6.2.5. Manufacturer & Distributor List (Top 5)
6.2.6. Company Market Share (Top 3-5)
6.2.7. Economic Impact Study on North America Influenza Diagnostics Market
7. Europe Influenza Diagnostics Market Overview
7.1. Europe Influenza Diagnostics Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. Europe Influenza Diagnostics Market Share & Forecast, 2016-2027
7.2.1. By Test Type
7.2.1.1. Traditional Diagnostic Tests
7.2.1.1.1. RIDT
7.2.1.1.2. Viral Culture
7.2.1.1.3. DFA
7.2.1.1.4. Serological Assays
7.2.1.2. Molecular Diagnostic Tests
7.2.1.2.1. RT-PCR
7.2.1.2.2. Isothermal Nucleic Acid Amplification Tests
7.2.1.2.3. Others
7.2.1.3. Others
7.2.2. By End-User
7.2.2.1. Hospital
7.2.2.2. Clinical Laboratories
7.2.2.3. Research Centers
7.2.2.4. Point Of Care Testing Centers
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. UK
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Rest of Europe
7.2.4. Price-Point Analysis
7.2.5. Manufacturer & Distributor List (Top 5)
7.2.6. Company Market Share (Top 3-5)
7.2.7. Economic Impact Study on Europe Influenza Diagnostics Market
8. Asia Pacific Influenza Diagnostics Market Overview
8.1. Asia Pacific Influenza Diagnostics Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Influenza Diagnostics Market Share & Forecast, 2016-2027
8.2.1. By Test Type
8.2.1.1. Traditional Diagnostic Tests
8.2.1.1.1. RIDT
8.2.1.1.2. Viral Culture
8.2.1.1.3. DFA
8.2.1.1.4. Serological Assays
8.2.1.2. Molecular Diagnostic Tests
8.2.1.2.1. RT-PCR
8.2.1.2.2. Isothermal Nucleic Acid Amplification Tests
8.2.1.2.3. Others
8.2.1.3. Others
8.2.2. By End-User
8.2.2.1. Hospital
8.2.2.2. Clinical Laboratories
8.2.2.3. Research Centers
8.2.2.4. Point Of Care Testing Centers
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. Australia
8.2.3.5. Rest of Asia Pacific
8.2.4. Price-Point Analysis
8.2.5. Manufacturer & Distributor List (Top 5)
8.2.6. Company Market Share (Top 3-5)
8.2.7. Economic Impact Study on Asia Pacific Influenza Diagnostics Market
9. South America Influenza Diagnostics Market Overview
9.1. South America Influenza Diagnostics Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Influenza Diagnostics Market Share & Forecast, 2016-2027
9.2.1. By Test Type
9.2.1.1. Traditional Diagnostic Tests
9.2.1.1.1. RIDT
9.2.1.1.2. Viral Culture
9.2.1.1.3. DFA
9.2.1.1.4. Serological Assays
9.2.1.2. Molecular Diagnostic Tests
9.2.1.2.1. RT-PCR
9.2.1.2.2. Isothermal Nucleic Acid Amplification Tests
9.2.1.2.3. Others
9.2.1.3. Others
9.2.2. By End-User
9.2.2.1. Hospital
9.2.2.2. Clinical Laboratories
9.2.2.3. Research Centers
9.2.2.4. Point Of Care Testing Centers
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Argentina
9.2.3.3. Rest of South America
9.2.4. Price-Point Analysis
9.2.5. Manufacturer & Distributor List (Top 5)
9.2.6. Company Market Share (Top 3-5)
9.2.7. Economic Impact Study on South America Influenza Diagnostics Market
10. Middle East & Africa Influenza Diagnostics Market Overview
10.1. Middle East & Africa Influenza Diagnostics Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Influenza Diagnostics Market Share & Forecast, 2016-2027
10.2.1. By Test Type
10.2.1.1. Traditional Diagnostic Tests
10.2.1.1.1. RIDT
10.2.1.1.2. Viral Culture
10.2.1.1.3. DFA
10.2.1.1.4. Serological Assays
10.2.1.2. Molecular Diagnostic Tests
10.2.1.2.1. RT-PCR
10.2.1.2.2. Isothermal Nucleic Acid Amplification Tests
10.2.1.2.3. Others
10.2.1.3. Others
10.2.2. By End-User
10.2.2.1. Hospital
10.2.2.2. Clinical Laboratories
10.2.2.3. Research Centers
10.2.2.4. Point Of Care Testing Centers
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of Middle East & Africa
10.2.4. Price-Point Analysis
10.2.5. Manufacturer & Distributor List (Top 5)
10.2.6. Company Market Share (Top 3-5)
10.2.7. Economic Impact Study on Middle East & Africa Influenza Diagnostics Market
11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. F. Hoffmann-La Roche AG
11.7.2. Quidel Corporation
11.7.3. Thermo Fisher Scientific
11.7.4. Abbott Laboratories
11.7.5. Hologic
11.7.6. Becton
11.7.7. Dickinson, and Company
11.7.8. DiaSorin S.p.A
11.7.9. Luminex Corporation
11.7.10. Meridian Bioscience
11.7.11. GenMark Diagnostics
11.7.12. SA Scientific
11.7.13. Sekisui Diagnostics
11.7.14. bioMérieux SA
11.7.15. Danaher Corporation
11.7.16. Siemens Healthineers
11.7.17. Tecan Trading AG
11.7.18. ELITech
11.7.19. Mast Group,
11.7.20. Other Prominent Players
